- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
PDGFR ‐β and kidney fibrosis ; volume:12 ; number:3 ; year:2020 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 3 (2020) (gesamt 3)
- Urheber
-
Ortiz, Alberto
- DOI
-
10.15252/emmm.201911729
- URN
-
urn:nbn:de:101:1-2022070408060552596813
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ortiz, Alberto
Ähnliche Objekte (12)
Kidney fibrosis: Emerging diagnostic and therapeutic strategies
Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
Role of MMP-2 and CD147 in kidney fibrosis
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
Dysregulated mesenchymal PDGFR-β drives kidney fibrosis
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis
EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
Dynamic multi-omics and mechanistic modeling of kidney fibrosis progression
Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice
Kidney fibrosis: Emerging diagnostic and therapeutic strategies
Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
Role of MMP-2 and CD147 in kidney fibrosis
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
Dysregulated mesenchymal PDGFR-β drives kidney fibrosis
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis
EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
Dynamic multi-omics and mechanistic modeling of kidney fibrosis progression
Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice
Kidney fibrosis: Emerging diagnostic and therapeutic strategies
Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
Role of MMP-2 and CD147 in kidney fibrosis
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
Dysregulated mesenchymal PDGFR-β drives kidney fibrosis
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis
EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
Dynamic multi-omics and mechanistic modeling of kidney fibrosis progression